The Allergic Rhinitis Drugs Market Report 2023-2033: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.
Advent of Innovative Intranasal Therapies for Treatment of Allergic Rhinitis
Intranasal therapies are gaining acceptance owing to their better safety and efficacy. This route of administration is also recommended by physicians and allergists since they do not have any systemic side-effects and their adequate concentrations can be achieved at receptor sides in nasal mucosa. Their adverse effects are limited to dryness, sneezing and stinging of nasal mucosa. Several companies are developing innovative intranasal drugs owing to their inherent advantages over other routes of administration. For instance, ClorNasal™ developed by Dr. Ferrer BioPharma is recognized as the best intranasal pharmacological formulation in the world. It is used in the treatment of several ailments including allergic rhinitis, Respiratory Syncytial Virus (RSV) Infection and COVID-19. Similarly, Altamira Therapeutics Ltd. Developed the nasal spray Bentrino. It prevents the onset of allergic symptoms by airborne allergens such as dust mites, and pollens.
Similarity of Symptoms With Other Diseases
Allergic rhinitis is an infection caused due to allergic reaction of immune system to an allergen. Some of the most common symptoms of allergic rhinitis include stuffy nose, watery eyes, itchy mouth, sneezing, post-nasal drip, sore throat, facial pain or pressure, partial loss of hearing, smell, and taste, and fatigue among others. The symptoms are very similar to cold and cough which might be caused by virus and not by any of the agents that cause allergies. The allergies can also trigger other conditions such as asthma, sinusitis, otitis media or eczema if not treatment well in time. Selection of the right drug candidate remains a major problem in the absence of accurate diagnosis. Administration of immunotherapy or allergy shots may have serious side effects such as hives and rash. It may sometimes have dangerous side effects such as anaphylaxis which may require years of treatment.
Adverse Effects of Drugs Used in Allergic Rhinitis Treatment
Allergic medications are mostly used over a long period of time to keep the lifestyle unaffected by different types of allergens in the environment. Antihistamines are the most widely used drug type for treatment of allergic infections. Some of the short-term side-effects of antihistamines include constipation, urinary retention, dry mouth, enhanced appetite, and worsen narrow-angle glaucoma. Several side-effects of nasal decongestants include high blood pressure, irritability, headache, and sleeplessness. Topical corticosteroids cause absorption of the drug into the systemic circulation which has potential to cause disturbance to the normal hormonal levels in the body. Corticosteroid ocular solutions can cause glaucoma, cataract and other eye infections. Intranasal corticosteroids can irritate nasal mucosa and also affect the cell lining of mouth and throat make them dry and soar. Oral corticosteroids are associated with side-effects such as osteoporosis, stomach ulceration, hyperglycaemia, increased blood pressure and muscle weakness.
What Questions Should You Ask before Buying a Market Research Report?
• How is the Allergic Rhinitis Drugs Market evolving?
• What is driving and restraining the Allergic Rhinitis Drugs Market?
• How will each Allergic Rhinitis Drugs submarket grow over the forecast period and how much revenue will these submarkets account for in 2033?
• How will the market shares for each Allergic Rhinitis Drugs submarket develop from 2023 to 2033?
• What will be the main driver for the overall market from 2023 to 2033?
• Will leading Allergic Rhinitis Drugs Markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?
• Who are the leading players and what are their prospects over the forecast period?
• What are the Allergic Rhinitis Drugs development projects for these leading companies?
• How will the industry evolve during the period between 2023 and 2033? What are the implications of Allergic Rhinitis Drugs development projects taking place now and over the next 10 years?
• Is there a greater need for product commercialisation to further scale the Allergic Rhinitis Drugs Market?
• Where is the Allergic Rhinitis Drugs Market heading and how can you ensure you are at the forefront of the market?
• What are the best investment options for new product and service lines?
• What are the key prospects for moving companies into a new growth path and C-suite?
You need to discover how this will impact the Allergic Rhinitis Drugs Market today, and over the next 10 years:
• Our 269-page report provides 105 tables and 173 charts/graphs exclusively to you.
• The report highlights key lucrative areas in the industry so you can target them – NOW.
• It contains in-depth analysis of global, regional and national sales and growth.
• It highlights for you the key successful trends, changes and revenue projections made by your competitors.
This report tells you TODAY how the Allergic Rhinitis Drugs Market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.
Forecasts to 2033 and other analyses reveal commercial prospects
• In addition to revenue forecasting to 2033, our new study provides you with recent results, growth rates, and market shares.
• You will find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising prices of allergic rhinitis drugs and recent developments.
This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.
Segments Covered in the Report
Treatment Type
• Antihistamines
• Immunotherapy
– Subcutaneous Immunotherapy (SCIT)
– Sublingual Immunotherapy (SLIT)
• Corticosteroids
• Decongestants
• Others
Disease Type
• Seasonal Allergic Rhinitis
• Perennial Allergic Rhinitis
• Occupational Allergic Rhinitis
Route of Administration
• Oral
• Nasal
• Intraocular
• Intravenous
Distribution Channel
• Retail Pharmacies
• Hospital Pharmacies
• Online channels
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 16 leading national markets:
North America
• U.S.
• Canada
Europe
• Germany
• UK
• France
• Spain
• Italy
• Russia
• Rest of Europe
Asia Pacific
• China
• Japan
• India
• Australia
• South Korea
• Rest of Asia Pacific
Latin America
• Brazil
• Mexico
• Rest of Latin America
MEA
• GCC
• South Africa
• Rest of MEA
Need industry data? Please contact us today.
The report also includes profiles and for some of the leading companies in the Allergic Rhinitis Drugs Market, 2023 to 2033, with a focus on this segment of these companies’ operations.
Leading companies and the potential for market growth
• Alcon
• AstraZeneca
• Bayer AG
• Dr Reddy’s Laboratories
• GlaxoSmithKline PLC
• Johnson & Johnson
• Merck & Co
• Sanofi S.A.
• Sun Pharmaceuticals
• Teva Pharmaceutical Industries Ltd
Overall world revenue for Allergic Rhinitis Drugs Market, 2023 to 2033 in terms of value the market will surpass US$12,410 million in 2023, our work calculates. We predict strong revenue growth through to 2033. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How will the Allergic Rhinitis Drugs Market, 2023 to 2033 report help you?
In summary, our 260+ page report provides you with the following knowledge:
• Revenue forecasts to 2033 for Allergic Rhinitis Drugs Market, 2023 to 2033 Market, with forecasts for Type of Treatment, Disease, Route of Administration and Distribution channel at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.
• Revenue forecasts to 2033 for five regional and 16 key national markets – See forecasts for the Allergic Rhinitis Drugs Market, 2023 to 2033 market in North America, Europe, Asia-Pacific and Latin America and Middle East and Africa. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
• Prospects for established firms and those seeking to enter the market – including company profiles of the major companies involved in the Allergic Rhinitis Drugs Market, 2023 to 2033.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.
Information found nowhere else
With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Allergic Rhinitis Drugs Market, 2023 to 2033, market-leading companies. You will find data, trends and predictions.
To access the data contained in this document please email contactus@visiongain.com
Buy our report today Allergic Rhinitis Drugs Market Report 2023-2033: Forecasts by Treatment (Antihistamines, Immunotherapy (SCIT, SLIT), Corticosteroids, Decongestants, Others), by Disease (Seasonal Allergic Rhinitis, Perennial Allergic Rhinitis, Occupational Allergic Rhinitis), by Route of Administration (Oral, Nasal, Intraocular, Intravenous), by Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Impact and Recovery Pattern Analysis. Avoid missing out by staying informed – order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: contactus@visiongain.com
1. Report Overview
1.1 Objectives of the Study
1.2 Introduction to Allergic Rhinitis Drugs Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report for?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain
2 Executive Summary
3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.2.1 Market Driving Factors
3.2.1.1 Growing Awareness About Allergies and Available Treatment Options
3.2.1.2 Increasing Prevalence of Respiratory Disorders
3.2.1.3 Launch of Effective and Novel Drug Delivery Systems
3.2.2 Market Restraining Factors
3.2.2.1 Adverse Effects of Drugs Used in Treatment of Allergic Rhinitis
3.2.2.2 Similarity of Symptoms with Other Diseases
3.2.3 Market Opportunities
3.2.3.1 Increasing Advancements in Allergen Immunotherapy (AIT)
3.2.3.2 Favourable Government Initiatives to Promote Awareness Regarding Allergic Rhinitis
3.3 COVID-19 Impact Analysis
3.4 Porter’s Five Forces Analysis
3.4.1 Bargaining Power of Suppliers
3.4.2 Bargaining Power of Buyers
3.4.3 Competitive Rivalry
3.4.4 Threat from Substitutes
3.4.5 Threat of New Entrants
3.5 PEST Analysis
4 Allergic Rhinitis Drugs Market Analysis by Treatment Type
4.1 Key Findings
4.2 Product Segment: Market Attractiveness Index
4.3 Allergic Rhinitis Drugs Market Size Estimation and Forecast by Treatment Type
4.4 Antihistamines
4.4.1 Market Size by Region, 2023-2033 (US$ Mn)
4.4.2 Market Share by Region, 2023 & 2033 (%)
4.5 Immunotherapy
4.5.1 Market Size by Region, 2023-2033 (US$ Mn)
4.5.2 Market Share by Region, 2023 & 2033 (%)
4.5.3 Sublingual immunotherapy (SLIT)
4.5.3.1 Market Size by Region, 2023-2033 (US$ Mn)
4.5.3.2 Market Share by Region, 2023 & 2033 (%)
4.5.4 Sublingual immunotherapy (SLIT)
4.5.4.1 Market Size by Region, 2023-2033 (US$ Mn)
4.5.4.2 Market Share by Region, 2023 & 2033 (%)
4.6 Corticosteroids
4.6.1 Market Size by Region, 2023-2033 (US$ Mn)
4.6.2 Market Share by Region, 2023 & 2033 (%)
4.7 Decongestants
4.7.1 Market Size by Region, 2023-2033 (US$ Mn)
4.7.2 Market Share by Region, 2023 & 2033 (%)
4.8 Others
4.8.1 Market Size by Region, 2023-2033 (US$ Mn)
4.8.2 Market Share by Region, 2023 & 2033 (%)
5 Allergic Rhinitis Drugs Market Analysis by Disease Type
5.1 Key Findings
5.2 Product Segment: Market Attractiveness Index
5.3 Allergic Rhinitis Drugs Market Size Estimation and Forecast by Disease Type
5.4 Seasonal Allergic Rhinitis
5.4.1 Market Size by Region, 2023-2033 (US$ Mn)
5.4.2 Market Share by Region, 2023 & 2033 (%)
5.5 Perennial Allergic Rhinitis
5.5.1 Market Size by Region, 2023-2033 (US$ Mn)
5.5.2 Market Share by Region, 2023 & 2033 (%)
5.6 Occupational Allergic Rhinitis
5.6.1 Market Size by Region, 2023-2033 (US$ Mn)
5.6.2 Market Share by Region, 2023 & 2033 (%)
6 Allergic Rhinitis Drugs Market Analysis by Route of Administration
6.1 Key Findings
6.2 Product Segment: Market Attractiveness Index
6.3 Allergic Rhinitis Drugs Market Size Estimation and Forecast by Route of Administration
6.4 Oral
6.4.1 Market Size by Region, 2023-2033 (US$ Mn)
6.4.2 Market Share by Region, 2023 & 2033 (%)
6.5 Nasal
6.5.1 Market Size by Region, 2023-2033 (US$ Mn)
6.5.2 Market Share by Region, 2023 & 2033 (%)
6.6 Intraocular
6.6.1 Market Size by Region, 2023-2033 (US$ Mn)
6.6.2 Market Share by Region, 2023 & 2033 (%)
6.7 Intravenous
6.7.1 Market Size by Region, 2023-2033 (US$ Mn)
6.7.2 Market Share by Region, 2023 & 2033 (%)
7 Allergic Rhinitis Drugs Market Analysis by Distribution Channel
7.1 Key Findings
7.2 Product Segment: Market Attractiveness Index
7.3 Allergic Rhinitis Drugs Market Size Estimation and Forecast by Distribution Channel
7.4 Retail Pharmacies
7.4.1 Market Size by Region, 2023-2033 (US$ Mn)
7.4.2 Market Share by Region, 2023 & 2033 (%)
7.5 Hospital Pharmacies
7.5.1 Market Size by Region, 2023-2033 (US$ Mn)
7.5.2 Market Share by Region, 2023 & 2033 (%)
7.6 Online Pharmacies
7.6.1 Market Size by Region, 2023-2033 (US$ Mn)
7.6.2 Market Share by Region, 2023 & 2033 (%)
8 Allergic Rhinitis Drugs Market Analysis by Region
8.1 Key Findings
8.2 Regional Segment: Market Attractiveness Index
8.3 Allergic Rhinitis Drugs Market Size Estimation and Forecast
9 North America Allergic Rhinitis Drugs Market Analysis
9.1 Key Findings
9.2 North America Allergic Rhinitis Drugs Market Attractiveness Index
9.3 North America Allergic Rhinitis Drugs Market by Country, 2023, 2028 & 2033 (US$ Mn)
9.4 North America Allergic Rhinitis Drugs Market Size Estimation and Forecast by Country
9.5 North America Allergic Rhinitis Drugs Market Size Estimation and Forecast by Treatment Type
9.6 North America Allergic Rhinitis Drugs Market Size Estimation and Forecast by Disease type
9.7 North America Allergic Rhinitis Drugs Market Size Estimation and Forecast by Route of Administration
9.8 North America Allergic Rhinitis Drugs Market Size Estimation and Forecast by Distribution Channel
9.9 U.S. Allergic Rhinitis Drugs Market Analysis
9.10 Canada Allergic Rhinitis Drugs Market Analysis
10 Europe Allergic Rhinitis Drugs Market Analysis
10.1 Key Findings
10.2 Europe Allergic Rhinitis Drugs Market Attractiveness Index
10.3 Europe Allergic Rhinitis Drugs Market by Country, 2023, 2028 & 2033 (US$ Mn)
10.4 Europe Allergic Rhinitis Drugs Market Size Estimation and Forecast by Country
10.5 Europe Allergic Rhinitis Drugs Market Size Estimation and Forecast by Treatment Type
10.6 Europe Allergic Rhinitis Drugs Market Size Estimation and Forecast by Disease type
10.7 Europe Allergic Rhinitis Drugs Market Size Estimation and Forecast by Route of Administration
10.8 Europe Allergic Rhinitis Drugs Market Size Estimation and Forecast by Distribution Channel
10.9 Germany Allergic Rhinitis Drugs Market Analysis
10.10 France Allergic Rhinitis Drugs Market Analysis
10.11 UK Allergic Rhinitis Drugs Market Analysis
10.12 Italy Allergic Rhinitis Drugs Market Analysis
10.13 Spain Allergic Rhinitis Drugs Market Analysis
10.14 Russia Allergic Rhinitis Drugs Market Analysis
10.15 Rest of Europe Allergic Rhinitis Drugs Market Analysis
11 Asia Pacific Allergic Rhinitis Drugs Market Analysis
11.1 Key Findings
11.2 Asia Pacific Allergic Rhinitis Drugs Market Attractiveness Index
11.3 Asia Pacific Allergic Rhinitis Drugs Market by Country, 2023, 2028 & 2033 (US$ Mn)
11.4 Asia Pacific Allergic Rhinitis Drugs Market Size Estimation and Forecast by Country
11.5 Asia Pacific Allergic Rhinitis Drugs Market Size Estimation and Forecast by Treatment Type
11.6 Asia Pacific Allergic Rhinitis Drugs Market Size Estimation and Forecast by Disease type
11.7 Asia Pacific Allergic Rhinitis Drugs Market Size Estimation and Forecast by Route of Administration
11.8 Asia Pacific Allergic Rhinitis Drugs Market Size Estimation and Forecast by Distribution Channel
11.9 Japan Allergic Rhinitis Drugs Market Analysis
11.10 China Allergic Rhinitis Drugs Market Analysis
11.11 India Allergic Rhinitis Drugs Market Analysis
11.12 Australia Allergic Rhinitis Drugs Market Analysis
11.13 South Korea Allergic Rhinitis Drugs Market Analysis
11.14 Rest of Asia Pacific Allergic Rhinitis Drugs Market Analysis
12 Latin America Allergic Rhinitis Drugs Market Analysis
12.1 Key Findings
12.2 Latin America Allergic Rhinitis Drugs Market Attractiveness Index
12.3 Latin America Allergic Rhinitis Drugs Market by Country, 2023, 2028 & 2033 (US$ Mn)
12.4 Latin America Allergic Rhinitis Drugs Market Size Estimation and Forecast by Country
12.5 Latin America Allergic Rhinitis Drugs Market Size Estimation and Forecast by Treatment Type
12.6 Latin America Allergic Rhinitis Drugs Market Size Estimation and Forecast by Disease type
12.7 Latin America Allergic Rhinitis Drugs Market Size Estimation and Forecast by Route of Administration
12.8 Latin America Allergic Rhinitis Drugs Market Size Estimation and Forecast by Distribution Channel
12.9 Brazil Allergic Rhinitis Drugs Market Analysis
12.10 Mexico Allergic Rhinitis Drugs Market Analysis
12.11 Rest of Latin America Allergic Rhinitis Drugs Market Analysis
13 MEA Allergic Rhinitis Drugs Market Analysis
13.1 Key Findings
13.2 MEA Allergic Rhinitis Drugs Market Attractiveness Index
13.3 MEA Allergic Rhinitis Drugs Market by Country, 2023, 2028 & 2033 (US$ Mn)
13.4 MEA Allergic Rhinitis Drugs Market Size Estimation and Forecast by Country
13.5 MEA Allergic Rhinitis Drugs Market Size Estimation and Forecast by Treatment Type
13.6 MEA Allergic Rhinitis Drugs Market Size Estimation and Forecast by Disease type
13.7 MEA Allergic Rhinitis Drugs Market Size Estimation and Forecast by Route of Administration
13.8 MEA Allergic Rhinitis Drugs Market Size Estimation and Forecast by Distribution Channel
13.9 GCC Allergic Rhinitis Drugs Market Analysis
13.10 South Africa Allergic Rhinitis Drugs Market Analysis
13.11 Rest of MEA Allergic Rhinitis Drugs Market Analysis
14 Company Profiles
14.1 Competitive Landscape, 2021
14.2 ALCON AG
14.2.1 Company Snapshot
14.2.2 Company Overview
14.2.3 Financial Analysis
14.2.3.1 Net Revenue, 2017-2021
14.2.3.2 R&D, 2017-2021
14.2.3.3 Regional Market Shares, 2021
14.2.4 Product Benchmarking
14.2.5 Strategic Outlook
14.3 AstraZeneca plc
14.3.1 Company Snapshot
14.3.2 Company Overview
14.3.3 Financial Analysis
14.3.3.1 Net Revenue, 2017-2021
14.3.3.2 R&D, 2017-2021
14.3.3.3 Regional Market Shares, 2021
14.3.4 Product Benchmarking
14.3.5 Strategic Outlook
14.4 Bayer AG
14.4.1 Company Snapshot
14.4.2 Company Overview
14.4.3 Financial Analysis
14.4.3.1 Net Revenue, 2017-2021
14.4.3.2 R&D, 2017-2021
14.4.3.3 Regional Market Shares, 2021
14.4.4 Product Benchmarking
14.4.5 Strategic Outlook
14.5 Dr Reddy's Laboratories Ltd.
14.5.1 Company Snapshot
14.5.2 Company Overview
14.5.3 Financial Analysis
14.5.3.1 Net Revenue, 2017-2021
14.5.3.2 R&D, 2017-2021
14.5.3.3 Regional Market Shares, 2021
14.5.4 Product Benchmarking
14.5.5 Strategic Outlook
14.6 GlaxoSmithKline plc
14.6.1 Company Snapshot
14.6.2 Company Overview
14.6.3 Financial Analysis
14.6.3.1 Net Revenue, 2017-2021
14.6.3.2 R&D, 2017-2021
14.6.3.3 Regional Market Shares, 2021
14.6.4 Product Benchmarking
14.6.5 Strategic Outlook
14.7 Johnson & Johnson
14.7.1 Company Snapshot
14.7.2 Company Overview
14.7.3 Financial Analysis
14.7.3.1 Net Revenue, 2017-2021
14.7.3.2 R&D, 2017-2021
14.7.3.3 Regional Market Shares, 2021
14.7.4 Product Benchmarking
14.7.5 Strategic Outlook
14.8 Merck & Co.
14.8.1 Company Snapshot
14.8.2 Company Overview
14.8.3 Financial Analysis
14.8.3.1 Net Revenue, 2017-2021
14.8.3.2 R&D, 2017-2021
14.8.3.3 Regional Market Shares, 2021
14.8.4 Product Benchmarking
14.8.5 Strategic Outlook
14.9 Sanofi SA
14.9.1 Company Snapshot
14.9.2 Company Overview
14.9.3 Financial Analysis
14.9.3.1 Net Revenue, 2017-2021
14.9.3.2 R&D, 2017-2021
14.9.3.3 Regional Market Shares, 2021
14.9.4 Product Benchmarking
14.9.5 Strategic Outlook
14.10 Sun Pharmaceutical Industries Limited
14.10.1 Company Snapshot
14.10.2 Company Overview
14.10.3 Financial Analysis
14.10.3.1 Net Revenue, 2017-2021
14.10.3.2 R&D, 2017-2021
14.10.3.3 Regional Market Shares, 2021
14.10.4 Product Benchmarking
14.10.5 Strategic Outlook
14.11 Teva Pharmaceutical Industries Ltd.
14.11.1 Company Snapshot
14.11.2 Company Overview
14.11.3 Financial Analysis
14.11.3.1 Net Revenue, 2017-2021
14.11.3.2 R&D, 2017-2021
14.11.3.3 Regional Market Shares, 2021
14.11.4 Product Benchmarking
14.11.5 Strategic Outlook
15 Conclusion and Recommendations
15.1 Concluding Remarks from Visiongain
15.2 Recommendations for Market Players
List of Tables
Table 1 Allergic Rhinitis Drugs Market Snapshot, 2023 & 2033 (US$ million, CAGR %)
Table 2 Allergic Rhinitis Drugs Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)): “V” Shaped Recovery Scenario
Table 3 Allergic Rhinitis Drugs Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)): “U” Shaped Recovery Scenario
Table 4 Allergic Rhinitis Drugs Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)): “W” Shaped Recovery Scenario
Table 5 Allergic Rhinitis Drugs Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)): “L” Shaped Recovery Scenario
Table 6 Allergic Rhinitis Drugs Market Forecast by Treatment Type, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 7 Antihistamines Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 8 Immunotherapy Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 9 SCIT Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 10 SLIT Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 11 Corticosteroids Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 12 Decongestants Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 13 Others Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 14 Allergic Rhinitis Drugs Market Forecast by Disease type, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 15 Allergic Rhinitis Drugs Market Forecast by Disease Type , 2023-2033 (US$ million)
Table 16 Seasonal Allergic Rhinitis Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 17 Perennial Allergic Rhinitis Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 18 Occupational Allergic Rhinitis Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 19 Allergic Rhinitis Drugs Market Forecast by Route of Administration, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 20 Allergic Rhinitis Drugs Market Forecast by Route of Route of Administration, 2023-2033 (US$ million)
Table 21 Oral Allergic Rhinitis Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 22 Nasal Allergic Rhinitis Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 23 Intraocular Allergic Rhinitis Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 24 Intravenous Allergic Rhinitis Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 25 Allergic Rhinitis Drugs Market Forecast by Distribution Channel, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 26 Retail Pharmacies Allergic Rhinitis Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 27 Hospital Pharmacies Allergic Rhinitis Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 28 Online Pharmacies Allergic Rhinitis Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 29 Allergic Rhinitis Drugs Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 30 North America Allergic Rhinitis Drugs Market Forecast by Country
Table 31 North America Allergic Rhinitis Drugs Market Forecast by Treatment Type, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 32 North America Allergic Rhinitis Drugs Market Forecast by Disease type, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 33 North America Allergic Rhinitis Drugs Market Forecast by Route of Administration, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 34 North America Allergic Rhinitis Drugs Market Forecast by Distribution Channel, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 35 U.S. Allergic Rhinitis Drugs Market Forecast, 2023-2033 (US$ Mn, AGR %, CAGR %)
Table 36 Canada Allergic Rhinitis Drugs Market Forecast, 2023-2033 (US$ mn, AGR %, CAGR %)
Table 37 Europe Allergic Rhinitis Drugs Market Forecast by Country, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 38 Europe Allergic Rhinitis Drugs Market Forecast by Treatment Type, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 39 Europe Allergic Rhinitis Drugs Market Forecast by Disease type, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 40 Europe Allergic Rhinitis Drugs Market Forecast by Route of Administration, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 41 Europe Allergic Rhinitis Drugs Market Forecast by Distribution Channel, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 42 Germany Allergic Rhinitis Drugs Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 43 France Allergic Rhinitis Drugs Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 44 UK Allergic Rhinitis Drugs Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 45 Italy Allergic Rhinitis Drugs Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 46 Spain Allergic Rhinitis Drugs Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 47 Russia Allergic Rhinitis Drugs Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 48 Rest of Europe Allergic Rhinitis Drugs Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 49 Asia Pacific Allergic Rhinitis Drugs Market forecast by Country 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 50 Asia Pacific Allergic Rhinitis Drugs Market Forecast by Treatment Type, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 51 Asia Pacific Allergic Rhinitis Drugs Market Forecast by Disease type, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 52 Asia Pacific Allergic Rhinitis Drugs Market Forecast by Route of Administration, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 53 Asia Pacific Allergic Rhinitis Drugs Market Forecast by Distribution Channel, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 54 Japan Allergic Rhinitis Drugs Market Forecast, 2023-2033 (US$ million, AGR %)
Table 55 China Allergic Rhinitis Drugs Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 56 India Allergic Rhinitis Drugs Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 57 Australia Allergic Rhinitis Drugs Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 58 South Korea Allergic Rhinitis Drugs Market Forecast, 2023-2033 (US$ million, AGR %)
Table 59 Rest of Asia Pacific Allergic Rhinitis Drugs Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 60 Latin America Allergic Rhinitis Drugs Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 61 Latin America Allergic Rhinitis Drugs Market Forecast by Treatment Type, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 62 Latin America Allergic Rhinitis Drugs Market Forecast by Disease type, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 63 Latin America Allergic Rhinitis Drugs Market Forecast by Route of Administration, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 64 Latin America Allergic Rhinitis Drugs Market Forecast by Distribution Channel, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 65 Brazil Allergic Rhinitis Drugs Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 66 Mexico Allergic Rhinitis Drugs Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 67 Rest of Latin America Allergic Rhinitis Drugs Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 68 MEA Allergic Rhinitis Drugs forecast by Country 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 69 MEA Allergic Rhinitis Drugs Market Forecast by Treatment Type, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 70 MEA Allergic Rhinitis Drugs Market Forecast by Disease type, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 71 MEA Allergic Rhinitis Drugs Market Forecast by Route of Administration, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 72 MEA Allergic Rhinitis Drugs Market Forecast by Distribution Channel, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 73 GCC Allergic Rhinitis Drugs Market Forecast, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 74 South Africa Allergic Rhinitis Drugs Market Forecast, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 75 Rest of MEA Allergic Rhinitis Drugs Market Forecast, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 76 Alcon AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 77 Alcon AG: Product Benchmarking
Table 78 Alcon AG.: Strategic Outlook
Table 79 AstraZeneca plc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 80 AstraZeneca plc: Product Benchmarking
Table 81 AstraZeneca plc: Strategic Outlook
Table 82 Bayer AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 83 Bayer AG.: Product Benchmarking
Table 84 Bayer AG: Strategic Outlook
Table 85 Dr. Reddy’s Laboratories Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 86 Dr. Reddy’s Laboratories Ltd.: Product Benchmarking
Table 87 Dr. Reddy’s Laboratories Ltd.: Strategic Outlook
Table 88 GlaxoSmithKline plc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 89 GlaxoSmithKline plc.: Product Benchmarking
Table 90 GlaxoSmithKline plc: Strategic Outlook
Table 91 Johnson & Johnson: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 92 Johnson & Johnson: Product Benchmarking
Table 93 Johnson & Johnson: Strategic Outlook
Table 94 Merck & Co.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 95 Merck & Co.: Product Benchmarking
Table 96 Merck & Co.: Strategic Outlook
Table 97 Sanofi SA.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 98 Sanofi SA: Product Benchmarking
Table 99 Sanofi SA : Strategic Outlook
Table 100 Sun Pharmaceutical Industries Limited: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 101 Sun Pharmaceutical Industries Limited: Product Benchmarking
Table 102 Sun Pharmaceutical Industries Limited: Strategic Outlook
Table 103 Teva Pharmaceutical Industries Ltd.: (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 104 Teva Pharmaceutical Industries Ltd.: Product Benchmarking
Table 105 Teva Pharmaceutical Industries Ltd.: Strategic Outlook
List of Figures
Figure 1 Allergic Rhinitis Drugs Market Segmentation
Figure 2 Allergic Rhinitis Drugs Market by Treatment type: Market Attractiveness Index
Figure 3 Allergic Rhinitis Drugs Market Attractiveness Index by Disease type
Figure 4 Allergic Rhinitis Drugs Market Attractiveness Index by Route of Administration
Figure 5 Allergic Rhinitis Drugs Market Attractiveness Index by Distribution Channel
Figure 6 Allergic Rhinitis Drugs Market Attractiveness Index by Region
Figure 7 Allergic Rhinitis Drugs Market: Market Dynamics
Figure 8 COVID Impact Analysis: Allergic Rhinitis Drugs Market Recovery Scenarios
Figure 9 Allergic Rhinitis Drugs Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)): “V” Shaped Recovery
Figure 10 Allergic Rhinitis Drugs Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)): “U” Shaped Recovery
Figure 11 Allergic Rhinitis Drugs Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)): “W” Shaped Recovery
Figure 12 Allergic Rhinitis Drugs Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)): “L” Shaped Recovery
Figure 13 Allergic Rhinitis Drugs Market: Porter’s Five Forces Analysis
Figure 14 Allergic Rhinitis Drugs Market: PEST Analysis
Figure 15 Allergic Rhinitis Drugs Market by Treatment Type: Market Attractiveness Index
Figure 16 Allergic Rhinitis Drugs Market Forecast by Treatment Type, 2023-2033 (US$ million)
Figure 17 Allergic Rhinitis Drugs Market Share Forecast by Treatment Type, 2023-2033 (%)
Figure 18 Antihistamines Market Forecast by Region, 2023-2033 (US$ million)
Figure 19 Antihistamines Market Share Forecast by Region, 2023 & 2033 (%)
Figure 20 Immunotherapy Market Forecast by Region, 2023-2033 (US$ million)
Figure 21 Immunotherapy Market Share Forecast by Region, 2023 & 2033 (%)
Figure 22 SCIT Market Forecast by Region, 2023-2033 (US$ million)
Figure 23 SCIT Market Share Forecast by Region, 2023 & 2033 (%)
Figure 24 SLIT Market Forecast by Region, 2023-2033 (US$ million)
Figure 25 SLIT Market Share Forecast by Region, 2023 & 2033 (%)
Figure 26 Corticosteroids Market Forecast by Region, 2023-2033 (US$ million)
Figure 27 Corticosteroids Market Share Forecast by Region, 2023 & 2033 (%)
Figure 28 Decongestants Market Forecast by Region, 2023-2033 (US$ million)
Figure 29 Decongestants Market Share Forecast by Region, 2023 & 2033 (%)
Figure 30 Others Market Forecast by Region, 2023-2033 (US$ million)
Figure 31 Others Market Share Forecast by Region, 2023 & 2033 (%)
Figure 32 Allergic Rhinitis Drugs Market by Disease Type: Market Attractiveness Index
Figure 33 Allergic Rhinitis Drugs Market Share Forecast by Disease Type, 2023-2033 (%)
Figure 34 Seasonal Allergic Rhinitis Market Forecast by Region, 2023-2033 (US$ million)
Figure 35 Seasonal Allergic Rhinitis Market Share Forecast by Region, 2023 & 2033 (%)
Figure 36 Perennial Allergic Rhinitis Market Forecast by Region, 2023-2033 (US$ million)
Figure 37 Perennial Allergic Rhinitis Market Share Forecast by Region, 2023 & 2033 (%)
Figure 38 Occupational Allergic Rhinitis Market Forecast by Region, 2023-2033 (US$ million)
Figure 39 Occupational Allergic Rhinitis Market Share Forecast by Region, 2023 & 2033 (%)
Figure 40 Allergic Rhinitis Drugs Market by Route of Administration: Market Attractiveness Index
Figure 41 Allergic Rhinitis Drugs Market Share Forecast by Route of Administration, 2023-2033 (%)
Figure 42 Oral Allergic Rhinitis Market Forecast by Region, 2023-2033 (US$ million)
Figure 43 Oral Allergic Rhinitis Market Share Forecast by Region, 2023 & 2033 (%)
Figure 44 Nasal Allergic Rhinitis Market Forecast by Region, 2023-2033 (US$ million)
Figure 45 Nasal Allergic Rhinitis Market Share Forecast by Region, 2023 & 2033 (%)
Figure 46 Intraocular Allergic Rhinitis Market Forecast by Region, 2023-2033 (US$ million)
Figure 47 Intraocular Allergic Rhinitis Market Share Forecast by Region, 2023 & 2033 (%)
Figure 48 Intravenous Allergic Rhinitis Market Forecast by Region, 2023-2033 (US$ million)
Figure 49 Intravenous Allergic Rhinitis Market Share Forecast by Region, 2023 & 2033 (%)
Figure 50 Allergic Rhinitis Drugs Market by Distribution Channel: Market Attractiveness Index
Figure 51 Allergic Rhinitis Drugs Market Forecast by Distribution Channel, 2023-2033 (US$ million)
Figure 52 Allergic Rhinitis Drugs Market Share Forecast by Distribution Channel, 2023-2033 (%)
Figure 53 Retail Pharmacies Allergic Rhinitis Market Forecast by Region, 2023-2033 (US$ million)
Figure 54 Retail Pharmacies Allergic Rhinitis Market Share Forecast by Region, 2023 & 2033 (%)
Figure 55 Hospital Pharmacies Allergic Rhinitis Market Forecast by Region, 2023-2033 (US$ million)
Figure 56 Hospital Pharmacies Allergic Rhinitis Market Share Forecast by Region, 2023 & 2033 (%)
Figure 57 Online Pharmacies Allergic Rhinitis Market Forecast by Region, 2023-2033 (US$ million)
Figure 58 Online Pharmacies Allergic Rhinitis Market Share Forecast by Region, 2023 & 2033 (%)
Figure 59 Allergic Rhinitis Drugs Market by Region: Market Attractiveness Index
Figure 60 Allergic Rhinitis Drugs Market by Region, 2023-2033 (US$ Mn)
Figure 61 Allergic Rhinitis Drugs Market Share Forecast by Region 2023, 2033(%)
Figure 62 North America Allergic Rhinitis Drugs Market Attractiveness Index
Figure 63 North America Allergic Rhinitis Drugs Market by Region, 2023, 2028 & 2033 (US$ million)
Figure 64 North America Allergic Rhinitis Drugs Market Forecast by Country, 2023-2033 (US$ million)
Figure 65 North America Allergic Rhinitis Drugs Market Share Forecast by Country, 2023 & 2033 (%)
Figure 66 North America Allergic Rhinitis Drugs Market Forecast by Treatment Type, 2023-2033 (US$ million)
Figure 67 North America Allergic Rhinitis Drugs Market Share Forecast by Treatment Type, 2023 & 2033 (%)
Figure 68 North America Allergic Rhinitis Drugs Market Forecast by Disease type, 2023-2033 (US$ million)
Figure 69 North America Allergic Rhinitis Drugs Market Share Forecast by Disease type, 2023 & 2033 (%)
Figure 70 North America Allergic Rhinitis Drugs Market Forecast by Route of Administration, 2023-2033 (US$ million)
Figure 71 North America Allergic Rhinitis Drugs Market Share Forecast by Route of Administration, 2023 & 2033 (%)
Figure 72 North America Allergic Rhinitis Drugs Market Forecast by Distribution Channel, 2023-2033 (US$ million)
Figure 73 North America Allergic Rhinitis Drugs Market Share Forecast by Distribution Channel, 2023 & 2033 (%)
Figure 74 U.S. Allergic Rhinitis Drugs Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 75 Canada Allergic Rhinitis Drugs Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 76 Europe Allergic Rhinitis Drugs Market Attractiveness Index
Figure 77 Europe Allergic Rhinitis Drugs Market by Region, 2023, 2028 & 2033 (US$ million)
Figure 78 Europe Allergic Rhinitis Drugs Market Forecast by Country, 2023-2033 (US$ million)
Figure 79 Europe Allergic Rhinitis Drugs Market Share Forecast by Country, 2023 & 2033 (%)
Figure 80 Europe Allergic Rhinitis Drugs Market Forecast by Treatment Type, 2023-2033 (US$ million)
Figure 81 Europe Allergic Rhinitis Drugs Market Share Forecast by Treatment Type, 2023 & 2033 (%)
Figure 82 Europe Allergic Rhinitis Drugs Market Forecast by Disease type, 2023-2033 (US$ million)
Figure 83 Europe Allergic Rhinitis Drugs Market Share Forecast by Disease type, 2023 & 2033 (%)
Figure 84 Europe Allergic Rhinitis Drugs Market Forecast by Route of Administration, 2023-2033 (US$ million)
Figure 85 Europe Allergic Rhinitis Drugs Market Share Forecast by Route of Administration, 2023 & 2033 (%)
Figure 86 Europe Allergic Rhinitis Drugs Market Forecast by Distribution Channel, 2023-2033 (US$ million)
Figure 87 Europe Allergic Rhinitis Drugs Market Share Forecast by Distribution Channel, 2023 & 2033 (%)
Figure 88 Germany Allergic Rhinitis Drugs Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 89 France Allergic Rhinitis Drugs Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 90 UK Allergic Rhinitis Drugs Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 91 Italy Allergic Rhinitis Drugs Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 92 Spain Allergic Rhinitis Drugs Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 93 Russia Allergic Rhinitis Drugs Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 94 Rest of Europe Allergic Rhinitis Drugs Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 95 Asia Pacific Allergic Rhinitis Drugs Market Attractiveness Index
Figure 96 Asia Pacific Allergic Rhinitis Drugs Market by Region, 2023, 2028 & 2033 (US$ million)
Figure 97 Asia Pacific Allergic Rhinitis Drugs Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 98 Asia Pacific Allergic Rhinitis Drugs Market Share Forecast by Country, 2023 & 2033 (%)
Figure 99 Asia Pacific Allergic Rhinitis Drugs Market Forecast by Treatment Type, 2023-2033 (US$ million)
Figure 100 Asia Pacific Allergic Rhinitis Drugs Market Share Forecast by Treatment Type, 2023 & 2033 (%)
Figure 101 Asia Pacific Allergic Rhinitis Drugs Market Forecast by Disease type, 2023-2033 (US$ million)
Figure 102 Asia Pacific Allergic Rhinitis Drugs Market Share Forecast by Disease type, 2023 & 2033 (%)
Figure 103 Asia Pacific Allergic Rhinitis Drugs Market Forecast by Route of Administration, 2023-2033 (US$ million)
Figure 104 Asia Pacific Allergic Rhinitis Drugs Market Share Forecast by Route of Administration, 2023 & 2033 (%)
Figure 105 Asia Pacific Allergic Rhinitis Drugs Market Forecast by Distribution Channel, 2023-2033 (US$ million)
Figure 106 Asia Pacific Allergic Rhinitis Drugs Market Share Forecast by Distribution Channel, 2023 & 2033 (%)
Figure 107 Japan Allergic Rhinitis Drugs Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 108 China Allergic Rhinitis Drugs Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 109 India Allergic Rhinitis Drugs Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 110 Australia Allergic Rhinitis Drugs Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 111 South Korea Allergic Rhinitis Drugs Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 112 Rest of Asia Pacific Allergic Rhinitis Drugs Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 113 Latin America Allergic Rhinitis Drugs Market Attractiveness Index
Figure 114 Latin America Allergic Rhinitis Drugs Market by Country, 2023, 2028 & 2033 (US$ million)
Figure 115 Latin America Allergic Rhinitis Drugs Market Forecast by Country, 2023-2033 (US$ million)
Figure 116 Latin America Allergic Rhinitis Drugs Market Share Forecast by Country, 2023 & 2033 (%)
Figure 117 Latin America Allergic Rhinitis Drugs Market Forecast by Treatment Type, 2023-2033 (US$ million)
Figure 118 Latin America Allergic Rhinitis Drugs Market Share Forecast by Treatment Type, 2023 & 2033 (%)
Figure 119 Latin America Allergic Rhinitis Drugs Market Forecast by Disease type, 2023-2033 (US$ million)
Figure 120 Latin America Allergic Rhinitis Drugs Market Share Forecast by Disease type, 2023 & 2033 (%)
Figure 121 Latin America Allergic Rhinitis Drugs Market Forecast by Route of Administration, 2023-2033 (US$ million)
Figure 122 Latin America Allergic Rhinitis Drugs Market Share Forecast by Route of Administration, 2023 & 2033 (%)
Figure 123 Latin America Allergic Rhinitis Drugs Market Forecast by Distribution Channel, 2023-2033 (US$ million)
Figure 124 Latin America Allergic Rhinitis Drugs Market Share Forecast by Distribution Channel, 2023 & 2033 (%)
Figure 125 Brazil Allergic Rhinitis Drugs Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 126 Mexico Allergic Rhinitis Drugs Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 127 Rest of Latin America Allergic Rhinitis Drugs Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 128 MEA Allergic Rhinitis Drugs Market Attractiveness Index
Figure 129 MEA Allergic Rhinitis Drugs Market by Country, 2023, 2028 & 2033 (US$ million)
Figure 130 MEA Allergic Rhinitis Drugs Market Forecast by Country, 2023-2033 (US$ million)
Figure 131 MEA Allergic Rhinitis Drugs Market Share Forecast by Country, 2023 & 2033 (%)
Figure 132 MEA Allergic Rhinitis Drugs Market Forecast by Treatment Type, 2023-2033 (US$ million)
Figure 133 MEA Allergic Rhinitis Drugs Market Share Forecast by Treatment Type, 2023 & 2033 (%)
Figure 134 MEA Allergic Rhinitis Drugs Market Forecast by Disease type, 2023-2033 (US$ million)
Figure 135 MEA Allergic Rhinitis Drugs Market Share Forecast by Disease type, 2023 & 2033 (%)
Figure 136 MEA Allergic Rhinitis Drugs Market Forecast by Route of Administration, 2023-2033 (US$ million)
Figure 137 MEA Allergic Rhinitis Drugs Market Share Forecast by Route of Administration, 2023 & 2033 (%)
Figure 138 MEA Allergic Rhinitis Drugs Market Forecast by Distribution Channel, 2023-2033 (US$ million)
Figure 139 MEA Allergic Rhinitis Drugs Market Share Forecast by Distribution Channel, 2023 & 2033 (%)
Figure 140 GCC Allergic Rhinitis Drugs Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 141 South Africa Allergic Rhinitis Drugs Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 142 Rest of MEA Allergic Rhinitis Drugs Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 143 Company Share Analysis, 2021
Figure 144 Alcon AG: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 145 Alcon AG: R&D, 2017-2021 (US$ million, AGR%)
Figure 146 Alcon AG: Regional Market Shares, 2021
Figure 147 AstraZeneca plc: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 148 AstraZeneca plc; R&D, 2017-2021 (US$ million, AGR%)
Figure 149 AstraZeneca plc: Regional Market Shares, 2021
Figure 150 Bayer AG: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 151 Bayer AG.: R&D, 2017-2021 (US$ million, AGR%)
Figure 152 Bayer AG.: Regional Market Shares, 2021
Figure 153 Dr. Reddy’s Laboratories Ltd.: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 154 Dr. Reddy’s Laboratories Ltd.; R&D, 2017-2021 (US$ million, AGR%)
Figure 155 Dr. Reddy’s Laboratories Ltd.: Regional Market Shares, 2021
Figure 156 GlaxoSmithKline plc: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 157 GlaxoSmithKline plc: R&D, 2017-2021 (US$ million, AGR%)
Figure 158 GlaxoSmithKline plc: Regional Market Shares, 2021
Figure 159 Johnson & Johnson: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 160 Johnson & Johnson.: R&D, 2017-2021 (US$ million, AGR%)
Figure 161 Johnson & Johnson.: Regional Market Shares, 2021
Figure 162 Merck & Co.: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 163 Merck & Co.: R&D, 2017-2021 (US$ million, AGR%)
Figure 164 Merck & Co.: Regional Market Shares, 2021
Figure 165 Sanofi SA: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 166 Sanofi SA.: R&D, 2017-2021 (US$ million, AGR%)
Figure 167 Sanofi.: Regional Market Shares, 2021
Figure 168 Sun Pharmaceutical Industries Limited: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 169 Sun Pharmaceutical Industries Limited.: R&D, 2017-2021 (US$ million, AGR%)
Figure 170 Sun Pharmaceutical Industries Limited.: Regional Market Shares, 2021
Figure 171 Teva Pharmaceutical Industries Ltd.: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 172 Teva Pharmaceutical Industries Ltd.: R&D, 2017-2021 (US$ million, AGR%)
Figure 173 Teva Pharmaceutical Industries Ltd.: Regional Market Shares, 2021
List of Companies Profiled in the Report
Alcon
AstraZeneca
Bayer AG
Dr Reddy's Laboratories
GlaxoSmithKline PLC
Johnson & Johnson
Merck & Co
Sanofi S.A.
Sun Pharmaceuticals
Teva Pharmaceutical Industries Ltd
List of Other Companies Mentioned in the Report
Aerie Pharmaceuticals, Inc.
Allermi
Altamira Therapeutics
Asklepios BioPharmaceutical
Blackstone
BlueRock Therapeutics
Cadila Pharmaceuticals
Eton Pharma
Glenmark Specialty SA
Hikma Pharmaceuticals PLC
ImmunoPrecise Antibodies
Nuance Pharma
Orna Therapeutics
PowerVision, Inc
Revelation Biosciences Inc.
Rimidi
Siolta Therapeutics
Taisho Pharmaceutical
Themis
Vence
Vir Biotechnology
List of Organizations Mentioned in the Report
American Academy of Allergy, Asthma & Immunology (AAAAI)
Australasian Society of Clinical Immunology and Allergy (ASCIA)
Canadian Society of Allergy and Clinical Immunology (CSACI)
European Academy of Allergy and Clinical Immunology (EAACI)
European Association of Allergy & Immunology (EAAI)
Global Alliance for Vaccines and Immunization (GAVI)
Japanese Society of Allergology (JSA)
Pan American Health Organization (PAHO)
Spanish Society of Allergology and Clinical Immunology (SEAIC)
The Asia Pacific Association of Allergy, Asthma and Clinical Immunology (APAAACI)
U.S. Department of Health and Human Services (HHS)
U.S. Food and Drug Administration (U.S.FDA)
United Nations International Children's Emergency Fund (UNICEF)
World Allergy Organization (WAO)
World Health Organization (WHO)
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
